Pancreatic cancer news
An exciting new partnership will see a combination of drugs tested in mesothelioma, lung and pancreatic cancers for the first time.
Cancer Research UK launches a first-of-its-kind pancreatic cancer clinical trial to make cancer cells more responsive to chemotherapy and radiotherapy.
New research has uncovered a possible explanation for why some cancers are more common than others, we explore the details.
Cancer Research UK has tripled its investment in pancreatic cancer, one of the hardest cancers to treat, since launching its research strategy in 2014.
Read about how we're approaching the challenge of understanding and treating lung, pancreatic, oesophageal cancers and brain tumours.